Transgene expression of NHE9 in GBM 276 resulted in the activation of multiple receptors detected on a phospho-RTK dot blot overlaid with GBM cell lysate (Figure S1D, Supplementary Material). The gene discussed is SLC9A9; the disease is glioblastoma.